Allison Barz Leahy

Allison Barz Leahy

UNVERIFIED PROFILE

Are you Allison Barz Leahy?   Register this Author

Register author
Allison Barz Leahy

Allison Barz Leahy

Publications by authors named "Allison Barz Leahy"

Are you Allison Barz Leahy?   Register this Author

10Publications

116Reads

45Profile Views

Commentary on King-Kallimanis et al.: Inadequate measurement of symptomatic adverse events in immunotherapy registration trials.

Clin Trials 2019 Jun 21;16(3):327-328. Epub 2019 Mar 21.

3 Division of Pediatric Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1740774519836989
Publisher Site
http://dx.doi.org/10.1177/1740774519836989DOI Listing
June 2019

Reporting standards for patient-reported outcomes in clinical trial protocols and publications.

J Natl Cancer Inst 2019 Apr 11. Epub 2019 Apr 11.

Division of Oncology, Children's Hospital of Philadelphia, Philadelphia , PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djz047DOI Listing
April 2019

Outcome Dimensions in Pediatric Palliative Care.

Pediatrics 2019 01 7;143(1). Epub 2018 Dec 7.

Department of Medical Ethics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; and.

View Article

Download full-text PDF

Source
http://pediatrics.aappublications.org/lookup/doi/10.1542/ped
Publisher Site
http://dx.doi.org/10.1542/peds.2018-3347DOI Listing
January 2019

Tisagenlecleucel for the treatment of B-cell acute lymphoblastic leukemia.

Expert Rev Anticancer Ther 2018 10;18(10):959-971

a Divisions of Pediatric Hematology and Oncology , Children's Hospital of Philadelphia, University of Pennsylvania, Perelman School of Medicine , Philadelphia , PA , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14737140.2018.1
Publisher Site
http://dx.doi.org/10.1080/14737140.2018.1512411DOI Listing
October 2018

Symptom Monitoring in Pediatric Oncology Using Patient-Reported Outcomes: Why, How, and Where Next.

Patient 2018 04;11(2):147-153

Department of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40271-017-0279-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845473PMC
April 2018

Reply to: Medication contaminants as a potential cause of anaphylaxis to vincristine: What about drug specific antigens?

Pediatr Blood Cancer 2018 02 19;65(2). Epub 2017 Oct 19.

Division of Allergy and Immunology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26868DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739934PMC
February 2018

Medication contaminants as a potential cause of anaphylaxis to vincristine.

Pediatr Blood Cancer 2018 Jan 22;65(1). Epub 2017 Aug 22.

Department of Pediatrics, Division of Allergy and Immunology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26761DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978699PMC
January 2018

Relationship Between State-Level Google Online Search Volume and Cancer Incidence in the United States: Retrospective Study.

J Med Internet Res 2018 01 8;20(1):e6. Epub 2018 Jan 8.

Penn Medicine Center for Digital Health, University of Pennsylvania, Philadelphia, PA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2196/jmir.8870DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778251PMC
January 2018